Enterprise Value
80.16M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
10.01%
Institutional Own.
46.49%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Pepaxto (Melflufen) Details Multiple myeloma | Phase 2 Update |